Stanley E. Althof
YOU?
Author Swipe
View article: (127) A Lifespan Perspective on Acquired Premature Ejaculation
(127) A Lifespan Perspective on Acquired Premature Ejaculation Open
Introduction This is the first manuscript to focus exclusively on the developmental course of Acquired Premature Ejaculation (APE). The aim is to retrospectively detail many of the APE experiences including age of onset, foreplay time, and…
View article: (129) A Lifespan Perspective on Lifelong Premature Ejaculation: Unresolved Issues and New Insights
(129) A Lifespan Perspective on Lifelong Premature Ejaculation: Unresolved Issues and New Insights Open
Introduction Despite the myriad of studies dealing with lifelong premature ejaculation (LPE), significant issues remain unresolved, including the age of onset relative to sexual debut, its constancy or variation over the lifespan, how it i…
View article: Symptoms and associated impact in pre- and postmenopausal women with sexual arousal disorder: a concept elicitation study
Symptoms and associated impact in pre- and postmenopausal women with sexual arousal disorder: a concept elicitation study Open
Background Approximately 26% of adult women in the United States suffer from female sexual arousal disorder (FSAD), yet little has been done to compare the experience of FSAD in pre- and postmenopausal women, which is critical to enhance t…
View article: The Unfinished Business of Defining Premature Ejaculation: The Need for Targeted Research
The Unfinished Business of Defining Premature Ejaculation: The Need for Targeted Research Open
The concepts underlying the diagnostic criteria for PE have both broad consensus and functional utility. Nevertheless, much of the research investigating PE has uncritically adopted these criteria without concomitantly recognizing their li…
View article: Development and Validation of the Satisfaction Survey for Inflatable Penile Implant (SSIPI)
Development and Validation of the Satisfaction Survey for Inflatable Penile Implant (SSIPI) Open
Background No validated English language patient-reported outcome (PRO) currently exists that assesses satisfaction with inflatable penile prosthesis (IPP). Satisfaction data have been largely based primarily on surgeon assessment of patie…
View article: MP39-15 DEVELOPMENT AND INTERNAL VALIDATION OF THE SATISFACTION SURVEY FOR INFLATABLE PENILE IMPLANT (SSIPI)
MP39-15 DEVELOPMENT AND INTERNAL VALIDATION OF THE SATISFACTION SURVEY FOR INFLATABLE PENILE IMPLANT (SSIPI) Open
You have accessJournal of UrologySexual Function/Dysfunction: Surgical Therapy II (MP39)1 Apr 2020MP39-15 DEVELOPMENT AND INTERNAL VALIDATION OF THE SATISFACTION SURVEY FOR INFLATABLE PENILE IMPLANT (SSIPI) Carolyn A. Salter*, Phi Vu Bach,…
View article: Premature Ejaculation (lifelong and acquired)
Premature Ejaculation (lifelong and acquired) Open
Ope n Pe e r Re v ie w on Qe ios
View article: MP84-07 PERFORMANCE AND CORRELATION OF EFFICACY ENDPOINTS IN A CLINICAL TRIAL OF PREMATURE EJACULATION
MP84-07 PERFORMANCE AND CORRELATION OF EFFICACY ENDPOINTS IN A CLINICAL TRIAL OF PREMATURE EJACULATION Open
You have accessJournal of UrologySexual Function/Dysfunction: Evaluation II1 Apr 2017MP84-07 PERFORMANCE AND CORRELATION OF EFFICACY ENDPOINTS IN A CLINICAL TRIAL OF PREMATURE EJACULATION Ray Rosen, Stanley Althof, Ian Osterloh, Gary Muirh…
View article: Psychosexual therapy for premature ejaculation
Psychosexual therapy for premature ejaculation Open
Premature ejaculation (PE) is a male sexual dysfunction that creates considerable anguish for the man, his partner and their relationship. PE is not one disorder but includes the four subtypes (lifelong, acquired, natural and subjective) e…
View article: Patient reported outcomes in the assessment of premature ejaculation
Patient reported outcomes in the assessment of premature ejaculation Open
The term 'Patient Reported Outcome', abbreviated as PRO, was introduced by the US Food and Drug Administration (FDA) which proposed guidance on the development and validation of PROs. Previously PROs were known as self-report diaries, even…
View article: Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial
Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial Open
Aim: Evaluate efficacy/safety of bremelanotide (BMT), a melanocortin-receptor-4 agonist, to treat female sexual dysfunctions in premenopausal women. Methods: Patients randomized to receive placebo or BMT 0.75, 1.25 or 1.75 mg self-administ…
View article: MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED?
MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED? Open
You have accessJournal of UrologySexual Function/Dysfunction: Basic Research & Pathophysiology II1 Apr 2016MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED? Michael Butcher, Wesley Baas, Aye Lwin, Bradley Holland, Michelle Herberts, Jos…
View article: Is There a Space to Improve the Treatment of Erectile Dysfunction in the Next Years? Opinion: Yes
Is There a Space to Improve the Treatment of Erectile Dysfunction in the Next Years? Opinion: Yes Open
Prior to the US approval of sildenafil in 1998, the available treatment options for erectile dyfunction (ED) included: intraurethral alprostadil (MUSE), intracavernosal injections (tri mix, alprostadil), vacuum pump therapy, placement of a…